Response of CD44+/CD24-/low breast cancer stem/progenitor cells to tamoxifen and doxorubicininduced autophagy

Author： Yenigun Vildan Betul   Ozpolat Bulent   Kose Gamze Torun  

Publisher： Spandidos Publications

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.31, Iss.6, 2013-06, pp. : 1477-1483

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stem/Progenitor Cells in Mouse Mammary Gland Development and Breast Cancer

By Li Yi   Rosen Jeffrey  

Journal of Mammary Gland Biology and Neoplasia, Vol. 10, Iss. 1, 2005-01 ,pp. : 17-24

Springer Publishing Company

Access to resources Recommend Favorite

Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer

By Blick Tony   Hugo Honor   Widodo Edwin   Waltham Mark   Pinto Cletus   Mani Sendurai   Weinberg Robert   Neve Richard   Lenburg Marc   Thompson Erik  

Journal of Mammary Gland Biology and Neoplasia, Vol. 15, Iss. 2, 2010-06 ,pp. : 235-252

Springer Publishing Company

Access to resources Recommend Favorite

Characteristic Genes in Luminal Subtype Breast Tumors with CD44+CD24–/Low Gene Expression Signature

By  

Oncology, Vol. 81, Iss. 5-6, 2012-01 ,pp. : 336-344

Karger

Access to resources Recommend Favorite

Circulating CD34+ hematopoietic stem/progenitor cells paralleled with level of viremia in patients chronically infected with hepatitis B virus

By Abdellatif Hussein  

Regenerative Medecine Research, Vol. 6, Iss. issue, 2018-02 ,pp. : 1-1

Edp Sciences

Access to resources Recommend Favorite